Seeing Is Believing
Currently out of the existing stock ratings of Jason Kolbert, 384 are a BUY (95.29%), 3 are a SELL (0.74%), 16 are a HOLD (3.97%).
Analyst Jason Kolbert, currently employed at DAWSON JAMES, carries an average stock price target met ratio of 38.65% that have a potential upside of 41.63% achieved within 428 days.
Jason Kolbert’s has documented 710 price targets and ratings displayed on 62 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ENLV, Enlivex Therapeutics Ltd at 22-Aug-2025.
Analyst best performing recommendations are on ARTL (ARTELO BIOSCIENCES).
The best stock recommendation documented was for ARTL (ARTELO BIOSCIENCES) at 6/6/2025. The price target of $6 was fulfilled within 7 days with a profit of $4.88 (435.71%) receiving and performance score of 622.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5 years 3 months 11 days ago
(13-May-2020)
0/2 (0%)
$7.2 (167.00%)
Hold
5 years 8 months 29 days ago
(26-Nov-2019)
0/1 (0%)
$1.7 (32.08%)
Which stock is Jason Kolbert is most bullish on?
Which stock is Jason Kolbert is most reserved on?
What Year was the first public recommendation made by Jason Kolbert?